AI-generated summary
This review of the literature examined published studies on laser treatment of primary cutaneous amyloidosis, a condition with cosmetic concerns and difficult treatment. The authors included eleven studies covering 64 patients and report significant improvement in macular and lichen amyloidosis with carbon dioxide laser in two studies, with good results from other laser types in case series and reports. The authors note the lack of large randomized controlled trials and the small sample size, and they describe laser treatment as a promising option.
- Participants
- 64
- Studies included
- 11
- Who or what was studied
- Patients with primary cutaneous amyloidosis (macular, lichen, and nodular forms)
- Limits stated in the abstract
- The review lacked large double-blinded randomized controlled trials and had an overall small sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.